CX Institutional’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.61M | Sell |
19,857
-869
| -4% | -$333K | 0.27% | 76 |
|
|
2025
Q1 | $7.16M | Buy |
20,726
+5,019
| +32% | +$1.73M | 0.27% | 86 |
|
|
2024
Q4 | $4.71M | Buy |
15,707
+2,185
| +16% | +$656K | 0.19% | 132 |
|
|
2024
Q3 | $5.5M | Buy |
13,522
+11,432
| +547% | +$4.65M | 0.24% | 110 |
|
|
2024
Q2 | $672K | Buy |
2,090
+242
| +13% | +$77.8K | 0.03% | 333 |
|
|
2024
Q1 | $616K | Sell |
1,848
-34
| -2% | -$11.3K | 0.03% | 341 |
|
|
2023
Q4 | $509K | Sell |
1,882
-68
| -3% | -$18.4K | 0.03% | 327 |
|
|
2023
Q3 | $480K | Buy |
1,950
+74
| +4% | +$18.2K | 0.03% | 334 |
|
|
2023
Q2 | $569K | Buy |
1,876
+59
| +3% | +$17.9K | 0.03% | 336 |
|
|
2023
Q1 | $480K | Buy |
1,817
+178
| +11% | +$47K | 0.03% | 350 |
|
|
2022
Q4 | $393K | Buy |
+1,639
| New | +$393K | 0.02% | 395 |
|
|
2022
Q3 | – | Sell |
-563
| Closed | -$95K | – | 753 |
|
|
2022
Q2 | $95K | Sell |
563
-313
| -36% | -$52.8K | 0.01% | 557 |
|
|
2022
Q1 | $220K | Buy |
+876
| New | +$220K | 0.02% | 347 |
|
|
2021
Q4 | – | Sell |
-695
| Closed | -$169K | – | 582 |
|
|
2021
Q3 | $169K | Buy |
695
+80
| +13% | +$19.5K | 0.01% | 371 |
|
|
2021
Q2 | $127K | Buy |
615
+122
| +25% | +$25.2K | 0.01% | 399 |
|
|
2021
Q1 | $93K | Buy |
493
+114
| +30% | +$21.5K | 0.01% | 389 |
|
|
2020
Q4 | $62K | Buy |
379
+209
| +123% | +$34.2K | 0.01% | 412 |
|
|
2020
Q3 | $21K | Buy |
170
+137
| +415% | +$16.9K | ﹤0.01% | 534 |
|
|
2020
Q2 | $3K | Sell |
33
-106
| -76% | -$9.64K | ﹤0.01% | 713 |
|
|
2020
Q1 | $12K | Buy |
139
+54
| +64% | +$4.66K | ﹤0.01% | 432 |
|
|
2019
Q4 | $13K | Buy |
85
+72
| +554% | +$11K | ﹤0.01% | 401 |
|
|
2019
Q3 | $2K | Sell |
13
-65
| -83% | -$10K | ﹤0.01% | 727 |
|
|
2019
Q2 | $11K | Buy |
78
+50
| +179% | +$7.05K | ﹤0.01% | 475 |
|
|
2019
Q1 | $4K | Buy |
+28
| New | +$4K | ﹤0.01% | 587 |
|